Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2300101	格菲妥单抗注射液	glofitamab	Injection	Biological Products(2.2)	Import Drug Application	2023-06-01	F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd	view
JYSB2400211	格菲妥单抗注射液	glofitamab	Injection	Biological Products(1)	Supplementary Application	2024-09-25	Genentech Inc;Roche Pharma (Schweiz) AG	view
JYSB2500144	格菲妥单抗注射液	glofitamab	Injection	Biological Products(1)	Supplementary Application	2025-06-24	Genentech Inc;Roche Pharma (Schweiz) AG	view
JYSB2400214	格菲妥单抗注射液	glofitamab	Injection	Biological Products	Supplementary Application	2024-09-25	Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG	view
JXSS2400072	格菲妥单抗注射液	glofitamab	Injection	Biological Products(2.2)	Import Drug Application	2024-09-05	Genentech Inc;Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd	view
JYSB2500041	格菲妥单抗注射液	glofitamab	Injection	Biological Products(1)	Supplementary Application	2025-02-19	Genentech Inc;Roche Pharma (Schweiz) AG	view
JYSB2400193	格菲妥单抗注射液	glofitamab	Injection	Biological Products(1)	Supplementary Application	2024-08-28	Genentech Inc;Roche Pharma (Schweiz) AG	view
JYSB2400215	格菲妥单抗注射液	glofitamab	Injection	Biological Products	Supplementary Application	2024-09-25	Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG	view